Titre : Hémostatiques

Hémostatiques : Questions médicales fréquentes

Termes MeSH sélectionnés :

Workforce
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Hémostatiques : Questions médicales les plus fréquentes", "headline": "Hémostatiques : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Hémostatiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-08", "dateModified": "2025-04-03", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Hémostatiques" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Coagulants", "url": "https://questionsmedicales.fr/mesh/D003029", "about": { "@type": "MedicalCondition", "name": "Coagulants", "code": { "@type": "MedicalCode", "code": "D003029", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.502.270" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Agents d'inversion des anticoagulants", "alternateName": "Anticoagulant Reversal Agents", "url": "https://questionsmedicales.fr/mesh/D000089964", "about": { "@type": "MedicalCondition", "name": "Agents d'inversion des anticoagulants", "code": { "@type": "MedicalCode", "code": "D000089964", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.502.270.463.046" } } }, { "@type": "MedicalWebPage", "name": "Antifibrinolytiques", "alternateName": "Antifibrinolytic Agents", "url": "https://questionsmedicales.fr/mesh/D000933", "about": { "@type": "MedicalCondition", "name": "Antifibrinolytiques", "code": { "@type": "MedicalCode", "code": "D000933", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.502.270.463.091" } } } ], "about": { "@type": "MedicalCondition", "name": "Hémostatiques", "alternateName": "Hemostatics", "code": { "@type": "MedicalCode", "code": "D006490", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Patricia Davenport", "url": "https://questionsmedicales.fr/author/Patricia%20Davenport", "affiliation": { "@type": "Organization", "name": "Division of Newborn Medicine, Boston Children's Hospital, Boston, MA, United States." } }, { "@type": "Person", "name": "Martha Sola-Visner", "url": "https://questionsmedicales.fr/author/Martha%20Sola-Visner", "affiliation": { "@type": "Organization", "name": "Division of Newborn Medicine, Boston Children's Hospital, Boston, MA, United States." } }, { "@type": "Person", "name": "Reihaneh Haghniaz", "url": "https://questionsmedicales.fr/author/Reihaneh%20Haghniaz", "affiliation": { "@type": "Organization", "name": "Terasaki Institute for Biomedical Innovation, Los Angeles, California 90024, United States." } }, { "@type": "Person", "name": "Ali Khademhosseini", "url": "https://questionsmedicales.fr/author/Ali%20Khademhosseini", "affiliation": { "@type": "Organization", "name": "Terasaki Institute for Biomedical Innovation, Los Angeles, California 90024, United States." } }, { "@type": "Person", "name": "A B Zemlyanoy", "url": "https://questionsmedicales.fr/author/A%20B%20Zemlyanoy", "affiliation": { "@type": "Organization", "name": "Pirogov National Medical and Surgical Center of Ministry of Health of Russia, Moscow, Russia." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Profile of the Oncology Physician Workforce and the Characteristics of Attrition.", "datePublished": "2023-05-15", "url": "https://questionsmedicales.fr/article/37186885", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1200/OP.22.00830" } }, { "@type": "ScholarlyArticle", "name": "A national survey of the radiotherapy dosimetrist workforce in the UK.", "datePublished": "2022-09-26", "url": "https://questionsmedicales.fr/article/36063424", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1259/bjr.20220459" } }, { "@type": "ScholarlyArticle", "name": "Telebehavioral Health: Workforce, Access, and Future Implications.", "datePublished": "2022-05-14", "url": "https://questionsmedicales.fr/article/35680247", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.psc.2022.03.008" } }, { "@type": "ScholarlyArticle", "name": "Impact of federalization for health financing and workforce in Nepal.", "datePublished": "2023-06-08", "url": "https://questionsmedicales.fr/article/37291678", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s41256-023-00304-3" } }, { "@type": "ScholarlyArticle", "name": "Steps toward a resilient future nurse workforce.", "datePublished": "2023-04-14", "url": "https://questionsmedicales.fr/article/37053471", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1515/ijnes-2022-0057" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Actions chimiques et utilisations", "item": "https://questionsmedicales.fr/mesh/D020164" }, { "@type": "ListItem", "position": 3, "name": "Actions pharmacologiques", "item": "https://questionsmedicales.fr/mesh/D020228" }, { "@type": "ListItem", "position": 4, "name": "Utilisations thérapeutiques", "item": "https://questionsmedicales.fr/mesh/D045506" }, { "@type": "ListItem", "position": 5, "name": "Agents hématologiques", "item": "https://questionsmedicales.fr/mesh/D006401" }, { "@type": "ListItem", "position": 6, "name": "Coagulants", "item": "https://questionsmedicales.fr/mesh/D003029" }, { "@type": "ListItem", "position": 7, "name": "Hémostatiques", "item": "https://questionsmedicales.fr/mesh/D006490" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Hémostatiques - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Hémostatiques", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Hémostatiques", "description": "Comment diagnostiquer un trouble de la coagulation ?\nQuels signes indiquent un besoin d'hémostatiques ?\nQuels tests pour évaluer l'efficacité des hémostatiques ?\nComment évaluer un saignement post-opératoire ?\nQuels antécédents médicaux sont pertinents ?", "url": "https://questionsmedicales.fr/mesh/D006490?mesh_terms=Workforce&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Hémostatiques", "description": "Quels sont les symptômes d'un saignement excessif ?\nComment reconnaître une hémorragie interne ?\nQuels signes d'alerte pour les troubles de la coagulation ?\nQuels symptômes d'une réaction aux hémostatiques ?\nComment identifier une thrombose ?", "url": "https://questionsmedicales.fr/mesh/D006490?mesh_terms=Workforce&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Hémostatiques", "description": "Comment prévenir les saignements chez les patients à risque ?\nQuels conseils pour éviter les saignements ?\nComment surveiller les patients sous anticoagulants ?\nQuelles mesures pour les patients hémophiles ?\nComment éduquer les patients sur les hémostatiques ?", "url": "https://questionsmedicales.fr/mesh/D006490?mesh_terms=Workforce&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Hémostatiques", "description": "Quels sont les principaux hémostatiques utilisés ?\nComment administrer des hémostatiques ?\nQuels traitements pour les saignements post-opératoires ?\nQuand utiliser des agents hémostatiques locaux ?\nQuels sont les effets secondaires des hémostatiques ?", "url": "https://questionsmedicales.fr/mesh/D006490?mesh_terms=Workforce&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Hémostatiques", "description": "Quelles complications peuvent survenir avec les hémostatiques ?\nComment gérer une réaction allergique aux hémostatiques ?\nQuels risques de thrombose avec des hémostatiques ?\nComment prévenir les complications liées aux hémostatiques ?\nQuels signes d'alerte pour des complications ?", "url": "https://questionsmedicales.fr/mesh/D006490?mesh_terms=Workforce&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Hémostatiques", "description": "Quels facteurs augmentent le risque de saignement ?\nComment l'âge influence-t-il le risque de saignement ?\nQuels médicaments augmentent le risque de saignement ?\nComment les maladies hépatiques affectent-elles la coagulation ?\nQuels comportements augmentent le risque de saignement ?", "url": "https://questionsmedicales.fr/mesh/D006490?mesh_terms=Workforce&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer un trouble de la coagulation ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins comme le temps de prothrombine et le temps de saignement sont utilisés." } }, { "@type": "Question", "name": "Quels signes indiquent un besoin d'hémostatiques ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des saignements excessifs, des ecchymoses fréquentes ou des saignements prolongés peuvent indiquer un besoin." } }, { "@type": "Question", "name": "Quels tests pour évaluer l'efficacité des hémostatiques ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "On utilise des tests comme le temps de thrombine et le temps de céphaline activé." } }, { "@type": "Question", "name": "Comment évaluer un saignement post-opératoire ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "On examine la quantité de sang perdu et la durée du saignement après la chirurgie." } }, { "@type": "Question", "name": "Quels antécédents médicaux sont pertinents ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents de troubles de la coagulation ou d'utilisation d'anticoagulants sont importants." } }, { "@type": "Question", "name": "Quels sont les symptômes d'un saignement excessif ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des ecchymoses, des saignements de nez fréquents et des gencives qui saignent." } }, { "@type": "Question", "name": "Comment reconnaître une hémorragie interne ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs abdominales, des vertiges ou une pâleur peuvent indiquer une hémorragie interne." } }, { "@type": "Question", "name": "Quels signes d'alerte pour les troubles de la coagulation ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des saignements prolongés après une coupure ou des saignements inhabituels sont des signes d'alerte." } }, { "@type": "Question", "name": "Quels symptômes d'une réaction aux hémostatiques ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des éruptions cutanées, des démangeaisons ou des difficultés respiratoires peuvent survenir." } }, { "@type": "Question", "name": "Comment identifier une thrombose ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Un gonflement, une douleur ou une rougeur dans une jambe peuvent indiquer une thrombose." } }, { "@type": "Question", "name": "Comment prévenir les saignements chez les patients à risque ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "On peut prescrire des hémostatiques préventifs avant des interventions chirurgicales." } }, { "@type": "Question", "name": "Quels conseils pour éviter les saignements ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les anticoagulants non prescrits et maintenir une bonne hygiène dentaire." } }, { "@type": "Question", "name": "Comment surveiller les patients sous anticoagulants ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Des contrôles réguliers de la coagulation sanguine sont nécessaires pour ajuster le traitement." } }, { "@type": "Question", "name": "Quelles mesures pour les patients hémophiles ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Les patients hémophiles doivent éviter les sports de contact et suivre un traitement préventif." } }, { "@type": "Question", "name": "Comment éduquer les patients sur les hémostatiques ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Informer sur l'utilisation correcte, les effets secondaires et l'importance du suivi médical." } }, { "@type": "Question", "name": "Quels sont les principaux hémostatiques utilisés ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les hémostatiques courants incluent l'acide tranexamique et la vitamine K." } }, { "@type": "Question", "name": "Comment administrer des hémostatiques ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent être administrés par voie orale, intraveineuse ou topique selon le type." } }, { "@type": "Question", "name": "Quels traitements pour les saignements post-opératoires ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "On peut utiliser des compresses, des sutures ou des hémostatiques pour contrôler le saignement." } }, { "@type": "Question", "name": "Quand utiliser des agents hémostatiques locaux ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Ils sont utilisés lors de chirurgies pour contrôler les saignements au site opératoire." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des hémostatiques ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure des réactions allergiques, des nausées ou des thromboses." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec les hémostatiques ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des thromboses, des réactions allergiques ou des troubles gastro-intestinaux." } }, { "@type": "Question", "name": "Comment gérer une réaction allergique aux hémostatiques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Il faut arrêter le traitement et administrer des antihistaminiques ou des corticostéroïdes si nécessaire." } }, { "@type": "Question", "name": "Quels risques de thrombose avec des hémostatiques ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "L'utilisation excessive d'hémostatiques peut augmenter le risque de thrombose veineuse profonde." } }, { "@type": "Question", "name": "Comment prévenir les complications liées aux hémostatiques ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical régulier et un ajustement des doses peuvent aider à prévenir les complications." } }, { "@type": "Question", "name": "Quels signes d'alerte pour des complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs thoraciques, des essoufflements ou des gonflements doivent alerter immédiatement." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de saignement ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux, l'utilisation d'anticoagulants et certaines maladies augmentent le risque." } }, { "@type": "Question", "name": "Comment l'âge influence-t-il le risque de saignement ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes âgées ont un risque accru de troubles de la coagulation et de saignements." } }, { "@type": "Question", "name": "Quels médicaments augmentent le risque de saignement ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Les anticoagulants, les anti-inflammatoires non stéroïdiens et certains antibiotiques peuvent augmenter le risque." } }, { "@type": "Question", "name": "Comment les maladies hépatiques affectent-elles la coagulation ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Les maladies hépatiques peuvent altérer la production de facteurs de coagulation, augmentant le risque de saignement." } }, { "@type": "Question", "name": "Quels comportements augmentent le risque de saignement ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "La consommation excessive d'alcool et le tabagisme peuvent augmenter le risque de saignement." } } ] } ] }

Sources (1648 au total)

Profile of the Oncology Physician Workforce and the Characteristics of Attrition.

To determine the prevalence of attrition and the frequency of transition from a primarily clinical role to an industry-related role among oncology physicians.... We tracked yearly Centers for Medicare & Medicaid Services (CMS) billing between 2015 and 2022 to estimate attrition of oncology physicians. A subanalysis of a random sample of 300 oncologists with fe... Of the 16,870 oncologists who billed to CMS in 2015, 3,558 (21%) had stopped billing by 2022. Among a randomly selected 300 oncologists, we found current employment information for 223 (74%); 78 of th... By 2022, 21% of oncology physicians billing to CMS in 2015 had stopped. 78 of the 300 sampled physicians were found to be working in industry. In total, 1 in 17 oncologists (5%) moved to industry over...

A national survey of the radiotherapy dosimetrist workforce in the UK.

To undertake a national survey of the Radiotherapy Dosimetrist workforce within the UK; examining different attributes and experiences, comparing results with published evidence within the literature.... A national, anonymised survey was undertaken between Dec 2020 and end of Feb 2021; employing a mixed-methods approach and blend of closed, open-ended answer choices and free-text comments. Questions i... A total of 223 individuals responded. Nearly half were trained via therapeutic radiography; approximately, a fifth through a clinical technologist/physics routes. Most (70%) had Dosimetrist in their j... Our survey showed a unique profile of the Radiotherapy Dosimetrist workforce in the UK, with a variety of training routes and statutory registration status. Nearly, a third were not engaged in a CPD s... A novel and unique national survey of Dosimetrists working in Radiotherapy in the UK is presented, leading to new insights into current training routes, registration status, job tasks and CPD engageme...

Steps toward a resilient future nurse workforce.

The psychosocial needs of nursing students are a pressing matter as mental health disorders may affect nursing students' journeys as professional nurses.... Psychological distress and burnout in nurses are threats to worldwide health care, as the stress associated with the COVID-19 pandemic could lead to an unstable future global nurse workforce.... Resiliency training can positively impact nurse stress, mindfulness, and resilience, as resilient nurses are better able to manage their response to stress and adversity which will contribute to posit... Educating faculty on resilience will aid nurse educators to create new student instructional approaches to improve mental health wellness.... Supportive faculty behaviors, self-care techniques, and resilience-building infused throughout the nursing curriculum may promote the effective transitioning of students into practice, providing the n...

Women's contribution to medicine in Bahrain: leadership and workforce.

Women make up a significant proportion of workforce in healthcare. However, they remain underrepresented in leadership positions relating to healthcare for a multitude of reasons: balancing personal a... Data were collected from the Bahraini Ministry of Health, National Health Regulatory Authority, Salmaniya Medical Complex, King Hamad University Hospital, Bahrain Defence Force Royal Medical Services,... The results of the study indicated that leadership positions were mostly held by males in Bahrain (59.4% vs. 40.6%). However, Bahraini males and females equally dominated academic positions. Male phys... This study highlights the increasing trend of women's participation and contribution to medicine in Bahrain. The data indicated continued growth in the number of female medical students and physicians...

CTC service heterogeneity and design of a workforce calculator.

To determine the level of heterogeneity in delivery of computed tomography (CT) colonography services and develop a workforce calculator that accommodates the variation identified.... A national survey, based on the "WHO workforce indicators of staffing need", established activity standards for essential tasks in delivery of the service. From these data a workforce calculator was d... Activity standards were established as mode responses >70%. Service homogeneity was greater in areas where professional standards and guidance were available. The mean service size was 1,101. Did not ... The survey identified benefits of radiographer-led direct booking and reporting. The workforce calculator derived from the survey provides a framework to guide the resourcing of expansion while mainta...

Update and projections for New Zealand's ophthalmology workforce.

The aim of this study was to update and project the growth of ophthalmologists in New Zealand. This will help decision makers better understand the current ophthalmologist workforce and make appropria... Supply and demographics of ophthalmologists in New Zealand were obtained from the Medical Council of New Zealand, Health Workforce New Zealand and Health New Zealand - Te Whatu Ora. Ophthalmology trai... In March 2023, there were 175 practising ophthalmologists in New Zealand. Overall, there were 34.0 ophthalmologists per million population, with 201.4 ophthalmologists per million for those aged ≥65 y... The ratio of ophthalmologists per million population aged ≥65 years is projected to drop by 1.5% annually. To meet the demand of an increasing and ageing population, and RANZCO's goal of 40 ophthalmol...